Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial.
about
Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Long-Term Safety and Efficacy ...... : A Phase 3, Open-Label Trial.
@en
Long-Term Safety and Efficacy ...... : A Phase 3, Open-Label Trial.
@nl
type
label
Long-Term Safety and Efficacy ...... : A Phase 3, Open-Label Trial.
@en
Long-Term Safety and Efficacy ...... : A Phase 3, Open-Label Trial.
@nl
prefLabel
Long-Term Safety and Efficacy ...... : A Phase 3, Open-Label Trial.
@en
Long-Term Safety and Efficacy ...... : A Phase 3, Open-Label Trial.
@nl
P2093
P2860
P356
P1433
P1476
Long-Term Safety and Efficacy ...... : A Phase 3, Open-Label Trial.
@en
P2093
Edward Michna
Joseph R Harper
Lynn R Webster
Robert J Israel
P2860
P304
P356
10.1093/PM/PNX148
P577
2017-08-01T00:00:00Z